A Multilevel Intervention to Improve Uptake of Gastrointestinal Cancer Screening: a Cluster Randomized Clinical Trial

NCT ID: NCT06830304

Last Updated: 2025-02-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

15000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-16

Study Completion Date

2025-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a cluster randomized controlled trial aimed at evaluating the effectiveness of a multi-level intervention strategy in improving adherence to gastrointestinal cancer screening. Communities will be randomly assigned as the unit of randomization to either intervention or control group. The study population includes community residents aged 50-74 years. Communities in the intervention group will receive multi-level interventions including health education, patient navigation services, and appointment assistance, while communities in the control group will maintain routine screening management. All participants will be followed up for 90 days to track their endoscopy appointment and completion rates. The main research question is:

Can community-based multi-level intervention effectively improve adherence to gastrointestinal cancer screening among community residents?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Screening Compliance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Arm

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention Group 1

Communities assigned to this arm will receive intervention including basic health education.

Group Type EXPERIMENTAL

Health education

Intervention Type BEHAVIORAL

Education Component:

1. Community level: Public awareness campaigns and educational sessions
2. Provider level: Training on screening guidelines and communication skills

Intervention Group2

Communities assigned to this arm will receive comprehensive multi-level interventions including health education and patient navigation services....

Group Type EXPERIMENTAL

Multi-level Education and Navigation Program for Gastrointestinal Cancer Screening

Intervention Type BEHAVIORAL

This multi-level intervention consists of two major components implemented at community, healthcare provider, and individual levels:

Education Component:

1. Community level: Public awareness campaigns and educational sessions
2. Provider level: Training on screening guidelines and communication skills
3. Individual level: Tailored educational materials and one-on-one counseling

Navigation Component:

1. Patient needs assessment and barrier identification
2. Personalized navigation services including:

Appointment scheduling assistance Transportation coordination Insurance/financial counseling Reminder calls/messages Social/psychological support

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Multi-level Education and Navigation Program for Gastrointestinal Cancer Screening

This multi-level intervention consists of two major components implemented at community, healthcare provider, and individual levels:

Education Component:

1. Community level: Public awareness campaigns and educational sessions
2. Provider level: Training on screening guidelines and communication skills
3. Individual level: Tailored educational materials and one-on-one counseling

Navigation Component:

1. Patient needs assessment and barrier identification
2. Personalized navigation services including:

Appointment scheduling assistance Transportation coordination Insurance/financial counseling Reminder calls/messages Social/psychological support

Intervention Type BEHAVIORAL

Health education

Education Component:

1. Community level: Public awareness campaigns and educational sessions
2. Provider level: Training on screening guidelines and communication skills

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* high-risk individuals of gastrointestinal cancer in 45-74 years old

Exclusion Criteria

* Unable to give consent
* history of cancer
* severe cardiac, pulmonary, brain, or renal dysfunction or any other serious disease
* psychiatric illness
* pregnancy
Minimum Eligible Age

45 Years

Maximum Eligible Age

74 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chongqing University Cancer Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chongqing University Cancer Hospital

Chongqing, Chongqing Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ChongqingCancer_GAS20240407

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.